Computer-Guided drug dosing shows promise for diabetic patients with liver disease
NCT ID NCT07439536
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether using a computer model to adjust doses of two common drugs (sitagliptin for diabetes and duloxetine for nerve pain) works better in people with liver cirrhosis. 64 patients with cirrhosis, diabetes, and nerve pain were grouped by liver severity and given personalized doses. Researchers measured blood sugar control and pain relief, while monitoring side effects and liver/kidney function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC NEUROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kafr El-Sheikh University
Cairo, Kafrelsheikh, 33511, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a sleep hormone ease diabetic nerve damage?
- Could a Once-Daily pill ease nerve pain just as well as the standard Twice-Daily dose?
- Can simple insoles or special exercises restore balance in diabetic nerve damage?
- Magnetic pulses may restore lost foot sensation in diabetes
- Worm extract shows promise for diabetic nerve pain
- Shocking new combo: spinal zaps and virtual reality ease diabetic nerve pain